Show simple item record

dc.contributor.authorAron Hjalti Björnsson
dc.contributor.authorÞorbjörg Ólafsdóttir
dc.contributor.authorKatrín María Þormar
dc.contributor.authorMár Kristjánsson
dc.contributor.authorAnna Sesselja Þórisdóttir
dc.contributor.authorBjörn Rúnar Lúðvíksson
dc.contributor.authorSigurður Guðmundsson
dc.contributor.authorMagnús Gottfreðsson
dc.date.accessioned2020-05-18T15:40:42Z
dc.date.available2020-05-18T15:40:42Z
dc.date.issued2020-05
dc.date.submitted2020-05
dc.identifier.citationAron Hjalti Björnsson, Þorbjörg Ólafsdóttir, Katrín María Þormar et al. Fyrsta meðferð með tocilizumab við COVID-19 hérlendis – sjúkratilfelli. Læknablaðið. 2020; 106(5): 247-250.en_US
dc.identifier.issn0023-7213
dc.identifier.urihttp://hdl.handle.net/2336/621409
dc.descriptionTo access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Downloaden_US
dc.description.abstractRúmlega fimmtugur karlmaður sem hafði verið á ferðalagi erlendis veiktist við komuna til landsins með flensulíkum einkennum og greindist með COVID-19. Nokkrum dögum síðar versnandi honum af öndunarfæraeinkennum og lagðist inn á Landspítala. Hann reyndist vera súrefnisháður og með útbreiddar íferðir í lungum. Eftir innlögn fékk hann versnandi öndunarbilun og var fluttur á gjörgæsludeild þar sem hann var meðal annars meðhöndlaður með tocilizumab (IL-6 hemill). Hann sýndi batamerki í kjölfarið og þurfti ekki að fara í öndunarvél.en_US
dc.description.abstractA gentleman in his early fifties became ill with flu-like symptoms after vacationing abroad and was diagnosed with COVID-19 after returning to Iceland. A few days later he was admitted to the University Hospital, Landspitali, due to worsening respiratory symptoms and severe fatigue. A computed tomography scan of lthe lungs showed diffuse bilateral consolidations and ground glass changes. He developed respiratory failure and was transferred to the intensive care unit where he received further treatment, including tocilizumab (IL-6 receptor inhibitor). He subsequently showed clinical improvement and did not require endotracheal intubation.en_US
dc.language.isoisen_US
dc.publisherLæknafélag Íslands, Læknafélag Reykjavíkuren_US
dc.relation.urlhttps://www.laeknabladid.is/tolublod/2020/05/nr/7338en_US
dc.subjectCOVID-19en_US
dc.subjectLyfjameðferðen_US
dc.subject.meshDrug Therapyen_US
dc.titleFyrsta meðferð með tocilizumab við COVID-19 hérlendis – sjúkratilfellien_US
dc.title.alternativeFirst case of COVID-19 treated with tocilizumab in Icelanden_US
dc.typeArticleen_US
dc.contributor.department1 Lyflækningasviði Landspítala, 2 röntgendeild, 3 svæfinga- og gjörgæsludeild, 4 smitsjúkdómadeild, 5 ónæmisfræðideild Landspítala, 6 læknadeild Háskóla Íslands.en_US
dc.identifier.journalLæknablaðiðen_US
dc.rights.accessOpen Access - Opinn aðganguren_US
dc.departmentcodeAAA12
dc.departmentcodeTMD12
dc.departmentcodeAAI12
refterms.dateFOA2020-05-18T15:40:42Z


Files in this item

Thumbnail
Name:
Fyrsta ....pdf
Size:
468.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record